Alaven Pharmaceutical LLC is categorized under Drug Brokers in Somerset, NJ and active since 2010.
Alaven Pharmaceutical LLC was established in 2010, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Hostler at the company’s single location by writing to 265 Davidson Avenue, Somerset, New Jersey NJ 08873 or by phoning (732) 564-2200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alaven Pharmaceutical LLC |
| Contact Person: | Jeffrey Hostler |
| Address: | 265 Davidson Avenue, Somerset, New Jersey 08873 |
| Phone Number: | (732) 564-2200 |
| Website Address: | meda.us |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Alaven Pharmaceutical LLC was started in 2010 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Jeffrey Hostler for inquiries that concern Alaven Pharmaceutical LLC by calling the company number (732) 564-2200, as your correspondence is most welcome. Additionally, the physical location of the single location of Alaven Pharmaceutical LLC can be found at the coordinates 40.533572,-74.527722 as well as the street address 265 Davidson Avenue in Somerset, New Jersey 08873.
For its online presence, you may visit Alaven Pharmaceutical LLC’s website at meda.us and engage with its social media outlets through on Twitter and on Facebook.